Digifluidic Bio-tech Co., Ltd.

Home
China
Guangdong
Digifluidic Bio-tech Co., Ltd.

Digifluidic is committed to developing precise automatic in Vitro Diagnostic Equipment. Digifluidic Biotech Ltd.

is a young and dynamic biotechnology company founded in 2018. With digital microfluidics as the core technology and automatic nucleic acid analysis system as the main product, Digifluidic is committed to developing precise automatic in vitro diagnostic equipment, whose application fields include medical disease diagnosis, animal and plant disease detection, health index detection, import and expor

t inspection and quarantine, food safety detection, etc., which shows infinite possibilities in the future. The nucleic acid detection equipment developed by Digifluidic at this stage has the characteristics of small size, easy to carry, simple operation and low cost. It solves the problems that traditional nucleic acid detection requires complex personnel operation and special detection sites. In the future, Digifluidic plans to cooperate with government agencies and scientific research institutions in different fields to develop various detection applications with different detection methods. In the medical field, Digifluidic aims to improve patient care, reduce costs and improve laboratory efficiency; in the non-medical field, Digifluidic aims to develop a variety of applications, improve people's quality of life and efficiency, and provide greater driving force for the future development of precision, automation and miniaturization of detection equipment.

11/08/2023

Recently, a joint research effort involving Professor Leibo's team from the Beijing Normal University-Hong Kong Baptist University United International College, Digifluidic, and collaborative partners
from Jinan University and Hong Kong Baptist University has resulted in the development of a visual detection platform based on Digital Microfluidics (DMF) technology and Loop-mediated Isothermal Amplification (LAMP) colorimetric reaction. This platform comprises multiple reaction units that can simultaneously detect multiple target genes in various samples, significantly improving detection efficiency.

A digital microfluidic platform coupled with colorimetric loopmediated isothermal amplification for on-site visual diagnosis of multiple diseases
Mei Xie, a,c Tianlan Chen, b Zongwei Cai, c Bo Leia* and Cheng D**g b,d**

https://doi.org/10.1039/D2LC01156E

10/07/2023

On July 20th, Digifluidic will unveil its latest generation of Point-of-Care Testing (POCT) integrated device, the Virus Hunter Plus, at this grand event. Four exhibition booths will be set up to provide explanations and consultations for each major application field.

We invite you to attend! This grand event will bridge the gap between regulatory authorities, experts, scholars, companies, and talent in the medical device industry, fostering consensus and empowering the industry to contribute to the integration and connectivity of global health.

Event Date: July 20, 2023
Event Venue: Multi-function Hall, Juxian Building, University of Macau
(N1-G008, NI-G014, N1G018)
Event Schedule - July 20th:
10:30 - Event Opening
10:50 - Product Launch
11:30 - Guest Speeches
12:00 - Signing Ceremony
13:00 - Symposium
14:00 - Buffet Lunch
14:30 - University of Macau Visit

Scan the QR code to register for the event!

06/06/2023

🔬 Exciting News! We are thrilled to announce that the research findings of DigiBio have been published in the prestigious international food science journal, Food Control (Q1, IF: 6.65). The groundbreaking study, titled "Multiplex detection of foodborne pathogens by real-time loop-mediated isothermal amplification on a digital microfluidic chip," demonstrates the immense potential of combining digital microfluidics with loop-mediated isothermal amplification for the detection of multiple foodborne pathogens.

💡 By leveraging the application of dried primers, this technology exhibits significant advantages in terms of multiplex detection, rapidity, and stability. Our future research endeavors will focus on further optimizing sample processing steps to achieve automated and rapid testing, thereby enhancing the efficiency and accuracy of microbial food contamination monitoring. The development of digital microfluidic technology is set to provide crucial support for the detection and control of foodborne pathogens in the food industry, ensuring public health and food safety.

Stay tuned for more updates on our groundbreaking advancements in food safety research! 🌱🔬🍽️

24/05/2023

Dr. Yubin Liang , leading a project team at Digifluidic Bio-tech Co., Ltd., is dedicated to establishing a multi-marker combined detection method. This method is based on two target genes, PCA3 and TMPRSS2-ERG, as well as an internal reference gene, PSA. Primers and probes were designed, and artificial synthesized pseudo-viruses and RNA from pathological white slides were used as templates for screening and optimizing the primers and probes. The Digifluidic Biotech team is committed to promoting high-quality health for all humankind. With the completion of this project, they hope to bring good news to the general public.

This innovative molecular diagnostic method will provide a new option for the screening and diagnosis of early-stage prostate cancer, offering patients a more convenient and non-invasive diagnostic approach. Our goal is to improve the early detection rate of prostate cancer, enabling patients to discover the disease early, develop effective treatment plans, and enhance their quality of life while extending their lifespan.

08/05/2023

The Chief Executive of Macau, Mr. He Yicheng, led a delegation of the Macau SAR Government and a delegation of Macao-Qin entrepreneurs to visit Lisbon, Portugal, from April 18 to 22. The purpose of the trip was to strengthen friendly relations, deepen areas of cooperation and explore opportunities for cooperation. In this action, the SAR Government delegation accompanying the Chief Executive on the visit included Secretary for Economy and Finance, Mr. Lee Wai Nong, Secretary for Transport and Works, Mr. Lo Lap Man, Director of the Chief Executive's Office, Ms. Hui Lai Fong, Director of the Secretary for Economy and Finance's Office, Ms. Koo Mei Ling, and a number of bureau heads. Dr. Chen Tianlan, General Manager of Zhuhai Digifluidic Biotechnology Co., Ltd. went along as part of the entrepreneurial delegation.

19/04/2023

On April 11th, Zhuhai Digifluidic BioTech Co., Ltd.'s VHunter S biochip reader was approved by the Guangdong Provincial Medical Products Administration and obtained a medical device registration certificate with registration number Guangdong Machinery Note 20232220597.

The acquisition of this medical device registration certificate not only enriches our company's product line but also improves our market share of similar products. As an explorer of digital microfluidic technology, Digifluidic BioTech has accumulated more than ten years of experience in the digital microfluidic molecular medicine research platform. The Virus Hunter series products developed based on digital microfluidic technology have advantages such as high-throughput detection, high integration application expansion, and multiple joint detection. The approval of this product fills the gap in similar domestic detection technology and provides more comprehensive decision-making basis for clinical diagnosis and treatment!

23/03/2023

"Looking for a faster and more efficient way to run multiple pathogen test? Check out digital microfluidic panels! With precise control over sample flow, these panels are revolutionizing lab work. "

14/03/2023

"Join the future of personalized medicine with our microfluidics platform!Our technology allows for precise and tailored diagnostics, enabling clinicians to select the most effective treatments for each patient. "

10/03/2023

"Our microfluidics platform is changing the game for disease screening and monitoring!With its ability to process small sample volumes, our technology provides fast and accurate results for a variety of infectious diseases, enabling earlier detection and treatment. "

08/03/2023

"Say goodbye to bulky and expensive lab equipment with our portable microfluidics platform!Our technology is small enough to fit in your backpack and provides accurate diagnostic results in real-time, making healthcare more accessible than ever before.

01/03/2023

The World Health Organization (WHO) has launched an updated priority pathogen list, a global scientific process to guide global investments and research in special areas such as vaccines, diagnostic tools, and treatments. WHO convened more than 300 scientists to review evidence on 25 virus families and bacteria, as well as "X diseases". The existing list includes COVID-19, Crimean-Congo hemorrhagic fever, Ebola virus disease, Marburg virus disease, Lassa fever, Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS), Nipah and Hendra viruses, Rift Valley fever, Zika and X diseases.

27/02/2023

Pets are like family to us and bring us joy, but there are currently about 200 known zoonotic diseases, with 89 of them being more significant. Pets can contract common viral diseases such as influenza, canine distemper, feline distemper, canine adenovirus, and feline adenovirus, as well as bacterial diseases such as rabies, feline infectious enteritis, and canine infectious enteritis. This is a potential risk to those with weakened immune systems, such as infants, the elderly, and pregnant women. Digital microfluidic technology offers many advantages for pet testing. It can quickly and accurately detect pathogens in the pet's body, and accurately measure and analyze the amount and type of proteins, nucleic acids, antibodies, antigens, bacteria, and viruses.

24/02/2023

Historians have recognized cases of food adulteration in Ancient Rome and the Middle Ages. Contemporary accounts of adulteration date from the 1850s to the present day. Since food adulteration is a huge concern in all parts of the globe. Many of the methods for detection of food adulteration require elaborate steps of sample preparation prior analysis involving high-end technologies and that makes the whole process difficult to perform and time consuming. Therefore, considerable interest has emerged in developing rapid methods for food-adulteration detection. Digital microfluidic technology can be used for food adulteration detection. It can rapidly and sensitively detect adulterated food. Digital microfluidic technology can detect adulterant substances in food, including amino acids, lipids, proteins, carbohydrates, and other organic substances. Additionally, it can be used to detect toxins and pesticide residues in food. Digital microfluidic technology can improve accuracy and sensitivity in food testing, helping testers to more quickly and accurately detect adulterated food.

21/02/2023

Digital microfluidic technology is making great strides in point-of-care diagnostics, providing more flexible and reliable testing solutions. POCT (Point of Care Testing) can use digital microfluidic technology to quickly and accurately test samples, saving time and costs.

12/10/2022

Aquatic disease detection for effective prevention and helps reduce losses.

Since there are no obvious clinical signs of EHP infection in shrimp within a short period of time, healthy shrimp must "cohabit" with EHP-infected shrimp, causing a huge disaster for shrimp farming. Therefore, it is necessary to develop an effective method to detect EHP-infected shrimp, especially in the early stages of infection. Currently, EHP detection methods are mainly through microscopic detection and molecular diagnostic methods.

29/09/2022

Establish an aquatic biological prevention system that detects first and prevents first.

EHP (Enterocytozoon hepatopenaei), an intracellular parasite that infects eukaryotes, can cause growth retardation and even death in shrimp if infected. It destroys the epithelial cells in the hepatopancreatic duct and prevents the absorption of nutrients in shrimp. Typical signs of EHP-infected shrimp are slow growth, stunted development, soft shell, and white stools. In Asian countries such as India, Thailand and China, EHP has been reported to cause a 10%-20% reduction in annual shrimp production, resulting in significant economic losses. And it is documented that EHP was first reported in 2009 among spot prawns in Thailand.

22/09/2022

Digifluidic develops DMF2.0A rapid nucleic acid detection equipment in aquatic disease field.

The DMF2.0A (aquatic disease field) rapid nucleic acid test is based on digital microfluidics, as the core technology, from the molecular level, fast, simple and accurate detection of shrimp diseases, such as EHP, YHV, IHHNV, WSSV, VP, VH, ect. Storage, transfer, result analysis, statistics and reporting, automatic interpretation of experimental results, can print the results; DMF2.0A aquatic disease field rapid nucleic acid detector on the machine detection time of only 100 minutes, the machine is lightweight and simple, easy to carry, on-site testing, suitable for all types of farms, fishery, and other outdoor testing.

16/09/2022

Digifluidic Completes Nearly RMB 100 Million Series A+ Financing

Zhuhai Digifluidic Biotechnology Co., Ltd (“Digifluidic” for short) recently announced the completion of a series A+ financing round of nearly RMB 100 million (about USD 15 million). This round of financing will be used to rapidly increase the market share of the company's products in the field of in vitro diagnostics, accelerate the company's R&D and production line process in the precision medical service industry, strengthen the domestic and overseas layout of the products, and consolidate Digifluidic's favorable market position in the nationalization of fully automated POCT products.

Address

Guangdong

Telephone

+8615919158075

Website

http://www.digifluidic.com/

Alerts

Be the first to know and let us send you an email when Digifluidic Bio-tech Co., Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Digifluidic Bio-tech Co., Ltd.: